ILB-202

· ILIAS Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ILB-202, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ILB-202 [Phase 1]